PL3562485T3 - Niehormonalne kompozycje i sposoby antykoncepcji u mężczyzn z wykorzystaniem (r)-silodozyny - Google Patents

Niehormonalne kompozycje i sposoby antykoncepcji u mężczyzn z wykorzystaniem (r)-silodozyny

Info

Publication number: PL3562485T3
Authority: PL; Poland
Prior art keywords: silodosin; methods; male contraception; hormonal compositions; hormonal
Prior art date: 2018-03-23

Application number

PL19714150T

Other languages

English (en)

Inventor

Guillaume El Glaoui

Medhi EL GLAOUI

Philippe Perrin

Stéphane DROUPY

Véronique AGATHON-MERIAU

Original Assignee

Laboratoires Major

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-03-23

Filing date

2019-03-22

Publication date

2020-11-16

2019-03-22 Application filed by Laboratoires Major filed Critical Laboratoires Major

2020-11-16 Publication of PL3562485T3 publication Critical patent/PL3562485T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

PL19714150T 2018-03-23 2019-03-22 Niehormonalne kompozycje i sposoby antykoncepcji u mężczyzn z wykorzystaniem (r)-silodozyny PL3562485T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201862763129P	2018-03-23	2018-03-23
EP18305328		2018-03-23
EP19714150.0A EP3562485B8 (en)	2018-03-23	2019-03-22	Non-hormonal compositions and methods for male contraception comprising (r)-silodosin
PCT/EP2019/057267 WO2019180217A1 (en)	2018-03-23	2019-03-22	Non-hormonal compositions and methods for male contraception

Publications (1)

Publication Number	Publication Date
PL3562485T3 true PL3562485T3 (pl)	2020-11-16

Family

ID=65955198

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL19714150T PL3562485T3 (pl)	2018-03-23	2019-03-22	Niehormonalne kompozycje i sposoby antykoncepcji u mężczyzn z wykorzystaniem (r)-silodozyny

Country Status (19)

Country	Link
US (3)	US10912762B2 (pl)
EP (2)	EP3562485B8 (pl)
JP (1)	JP7270901B2 (pl)
KR (1)	KR102496504B1 (pl)
CN (1)	CN112074269A (pl)
AU (1)	AU2019237228B2 (pl)
BR (1)	BR112020018925A2 (pl)
CA (1)	CA3094016C (pl)
DK (2)	DK3750538T3 (pl)
ES (1)	ES2813084T3 (pl)
FI (1)	FI3750538T3 (pl)
IL (1)	IL277372B2 (pl)
MA (1)	MA53626A (pl)
MX (1)	MX2020009937A (pl)
PL (1)	PL3562485T3 (pl)
PT (1)	PT3562485T (pl)
SG (1)	SG11202008794TA (pl)
UA (1)	UA128502C2 (pl)
WO (1)	WO2019180217A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL3562485T3 (pl) *	2018-03-23	2020-11-16	Laboratoires Major	Niehormonalne kompozycje i sposoby antykoncepcji u mężczyzn z wykorzystaniem (r)-silodozyny
US20240180871A1 (en)	2022-11-23	2024-06-06	Pharmajor Incorporated	Modified-release silodosin compositions and use thereof in methods for male contraception

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1091276A (en)	1911-12-09	1914-03-24	Basf Ag	Producing unsaturated terpene hydrocarbons.
US4210644A (en)	1978-02-23	1980-07-01	The Johns Hopkins University	Male contraception
DE4308406C1 (de)	1993-03-12	1994-06-16	Jenapharm Gmbh	Kombinationspräparat zur Kontrazeption
RU2002124602A (ru)	2000-02-15	2004-03-10	Шеринг Акциенгезелльшафт (De)	Композиция для мужской контрацепции, включающая норэтистерон
FR2861990B1 (fr) *	2003-11-10	2006-02-10	Nouveaux Produits Pharma	Comprimes faiblement doses a reseau de polymeres
US20090186896A1 (en) *	2005-09-29	2009-07-23	Bayer Healthcare Ag	PDE Inhibitors and Combinations Thereof for the Treatment of Urological Disorders
UA95085C2 (ru) *	2005-09-29	2011-07-11	Баер Шеринг Фарма Акциенгезельшафт	Применение варденафила для лечения урологических расстройств
AR063120A1 (es) *	2006-10-05	2008-12-30	Panacea Biotec Ltd	Composiciones inyectables de deposito y proceso para prepararlas
GB0700893D0 (en)	2007-01-17	2007-02-21	King S College London	Male contraceptive
MX2009009230A (es)	2007-02-28	2009-11-26	Kissei Pharmaceutical	Uso de silodosina en una administracion diaria para tratar hiperplasia prostatica benigna.
US20120184591A1 (en) *	2011-01-13	2012-07-19	Watson Pharmaceuticals, Inc.	Methods for treating prostatitis
CN102283816B (zh) *	2011-08-05	2013-09-11	北京海步国际医药科技发展有限公司	西洛多辛缓释片剂及其制备方法
WO2014118606A2 (en) *	2013-01-29	2014-08-07	Alembic Pharmaceuticals Limited	A novel process for the preparation of silodosin
WO2016051782A1 (ja)	2014-09-30	2016-04-07	キッセイ薬品工業株式会社	苦味を有する薬剤の苦味をマスキングした経口投与製剤
US20170049834A1 (en) *	2015-08-18	2017-02-23	Golden Biotechnology Corporation	Benign prostatic hyperplasia add-on therapy
PL3562485T3 (pl) *	2018-03-23	2020-11-16	Laboratoires Major	Niehormonalne kompozycje i sposoby antykoncepcji u mężczyzn z wykorzystaniem (r)-silodozyny

2019
- 2019-03-22 PL PL19714150T patent/PL3562485T3/pl unknown
- 2019-03-22 JP JP2021500350A patent/JP7270901B2/ja active Active
- 2019-03-22 UA UAA202006637A patent/UA128502C2/uk unknown
- 2019-03-22 FI FIEP20182691.4T patent/FI3750538T3/fi active
- 2019-03-22 US US16/362,081 patent/US10912762B2/en active Active
- 2019-03-22 IL IL277372A patent/IL277372B2/en unknown
- 2019-03-22 KR KR1020207029031A patent/KR102496504B1/ko active IP Right Grant
- 2019-03-22 EP EP19714150.0A patent/EP3562485B8/en active Active
- 2019-03-22 MX MX2020009937A patent/MX2020009937A/es unknown
- 2019-03-22 ES ES19714150T patent/ES2813084T3/es active Active
- 2019-03-22 SG SG11202008794TA patent/SG11202008794TA/en unknown
- 2019-03-22 MA MA053626A patent/MA53626A/fr unknown
- 2019-03-22 DK DK20182691.4T patent/DK3750538T3/da active
- 2019-03-22 AU AU2019237228A patent/AU2019237228B2/en active Active
- 2019-03-22 BR BR112020018925-1A patent/BR112020018925A2/pt unknown
- 2019-03-22 WO PCT/EP2019/057267 patent/WO2019180217A1/en active Application Filing
- 2019-03-22 PT PT197141500T patent/PT3562485T/pt unknown
- 2019-03-22 DK DK19714150.0T patent/DK3562485T3/da active
- 2019-03-22 EP EP20182691.4A patent/EP3750538B1/en active Active
- 2019-03-22 CN CN201980030077.4A patent/CN112074269A/zh active Pending
- 2019-03-22 CA CA3094016A patent/CA3094016C/en active Active
2020
- 2020-12-30 US US17/137,747 patent/US11583518B2/en active Active
2023
- 2023-01-06 US US18/093,940 patent/US11951095B2/en active Active

Also Published As

Publication number	Publication date
KR102496504B1 (ko)	2023-02-06
IL277372B2 (en)	2023-09-01
DK3750538T3 (da)	2024-09-23
EP3562485B1 (en)	2020-07-01
IL277372B1 (en)	2023-05-01
SG11202008794TA (en)	2020-10-29
US11583518B2 (en)	2023-02-21
JP2021518438A (ja)	2021-08-02
BR112020018925A2 (pt)	2020-12-29
CA3094016A1 (en)	2019-09-26
IL277372A (en)	2020-11-30
MA53626A (fr)	2022-03-09
US20210113526A1 (en)	2021-04-22
UA128502C2 (uk)	2024-07-31
US20190290615A1 (en)	2019-09-26
DK3562485T3 (da)	2020-08-24
AU2019237228A1 (en)	2020-10-01
RU2020134408A (ru)	2022-04-29
EP3750538B1 (en)	2024-08-14
CA3094016C (en)	2023-10-10
US10912762B2 (en)	2021-02-09
FI3750538T3 (fi)	2024-09-24
ES2813084T3 (es)	2021-03-22
RU2020134408A3 (pl)	2022-04-29
US11951095B2 (en)	2024-04-09
WO2019180217A1 (en)	2019-09-26
CN112074269A (zh)	2020-12-11
KR20200135978A (ko)	2020-12-04
EP3750538A1 (en)	2020-12-16
JP7270901B2 (ja)	2023-05-11
PT3562485T (pt)	2020-08-27
AU2019237228B2 (en)	2023-06-08
EP3562485A1 (en)	2019-11-06
EP3562485B8 (en)	2020-08-19
MX2020009937A (es)	2022-09-30
US20230145374A1 (en)	2023-05-11

Publication	Publication Date	Title
IL277079A (en)	2020-10-29	Cartirin preparations and methods of use
SG11202011761XA (en)	2020-12-30	Nicotine formulation
IL280134A (en)	2021-03-01	Anti-CD112R preparations and methods
IL280508A (en)	2021-03-01	The composition and methods of producing geopolymer
EP3659388A4 (en)	2021-04-21	METHOD AND RELATED DEVICE FOR ADDING SECONDARY NODES
IL280135A (en)	2021-03-01	Sodium Alagolix Compositions and Processes
IL268684A (en)	2019-10-31	Preparations and methods for immuno-oncology
EP3373870A4 (en)	2019-07-10	COMPOSITIONS AND METHODS FOR OCCLUSION CONTRACEPTION OF THE DEFENSE CHANNEL AND INVERSION THEREOF
SG11202104448WA (en)	2021-05-28	Compositions and methods
IL274524A (en)	2020-06-30	Preparations and methods for aquaculture
EP3807319A4 (en)	2022-05-25	COMPOSITIONS AND METHODS FOR INDUCING PHAGOCYTOSIS
EP3773654C0 (en)	2023-09-20	POLYPHARMACEUTICAL DRUG COMPOSITIONS AND ASSOCIATED METHODS
IL277372A (en)	2020-11-30	Non-hormonal preparations and methods for preventing pregnancy in men
IL277058A (en)	2020-10-29	Compositions and methods for inhibiting expression of GYS2
GB201819987D0 (en)	2019-01-23	Methods and compositions
GB201817444D0 (en)	2018-12-12	Methods and compositions
IL279877A (en)	2021-03-01	Ibusidanib forms and pharmaceutical preparations
SG11202103389WA (en)	2021-05-28	Immunogenic compositions
IL282515A (en)	2021-06-30	Preparations and methods for improving sperm function
RS64983B1 (sr)	2024-01-31	Intravaginalna formulacija
PT3750538T (pt)	2024-10-21	Métodos não-hormonais para a contracepção masculina compreendendo (r)-silodosina
SG11202011823SA (en)	2020-12-30	Activator-nucleator formulations
GB201819028D0 (en)	2019-01-09	Butanol-based formulations
GB201812022D0 (en)	2018-09-05	Pharmaceutical methods and compositions
GB201817902D0 (en)	2018-12-19	Methods and compositions